NEW research published in the
American Journal of Public Health
has found that co-administering
pneumococcal polysaccharide
vaccine (PPV23) together with the
seasonal influenza vaccine may
bolster pneumococcal
immunisation rates and help to
prevent additional hospitalisations
and mortality in the elderly and
other high-risk groups.
The review looked at nine clinical
studies, eight of which found a
concomitant program with the
PPV23 and seasonal influenza
vaccines conferred clinical benefits.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jun 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jun 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.